The American Civil Liberties Union also filed a lawsuit last week, alleging that the federal agency and its parent department ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

A dementia caregiver should be mindful of personality and behavior changes to best anticipate the patient’s needs. Find ...

Weight training may help protect the brains of older adults from dementia, including those already showing signs of mild ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Scientists at Ohio State University have made a surprising discovery about how brain cells may contribute to diseases like ...

Hypertension, or chronically high blood pressure, is a double whammy for the brain — making it harder for oxygen and ...